News summary
Newsletter text
[Shanghai promotes the Biomedical Industry Investment Fundshootyskies, aiming to help disruptive technological innovation] Shanghai plans to accelerate the establishment of a biomedical industry investment mother fund to promote the development of disruptive technologies. This move aims to strengthen investment-loan linkage and investment and financing cooperation, leverage the synergy of fiscal funds and funds, and attract capital to invest in early-stage, small and hard technology enterprises. The head of the Shanghai City Science and Technology Commission revealed at the 2024 Shanghai International Biotechnology and Medicine Symposium that the city will further improve the policy framework for the innovative development of the entire chain of the biomedical industry. It is expected that by deepening the integrated acceleration system of "R & D + clinical + manufacturing + application", innovative elements such as technology, talents, capital and data will be gathered. Shanghai also plans to create a better industrial ecology, enhance international open cooperation, and strengthen its international development capabilities. This move is expected to bring new development opportunities to Shanghai's biomedical industry.
